MDM2 and Hepatic steatosis: After 16 weeks of dietary treatment, under STC feeding hepatic lipid content of H‐MDM2‐KO mice was unchanged from that of WT controls, but liver‐specific deletion of MDM2 prevented HFHC diet‐induced hepatic steatosis (Figure 2B–D).